Iris Super Speciality Polyclinic Private Limited
About Iris Super Speciality Polyclinic Private Limited
Data last updated:
Iris Super Speciality Polyclinic Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 17 March 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U85100MH2020PTC338934. Its GSTIN is 27AAFCI6168M1ZZ (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Varadan Seshadri Cetlur and Ashok Kumar Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 116 Kailash Industrail Complex Veer Savarkar Marg Park, Mumbai, Maharashtra.
As per the financials filed for FY 2022, the company reported a revenue of ₹20.88 Lakh, a decline of 12% compared to the previous year. For the same year it recorded a net loss of ₹80.34 Lakh (net margin -384.8%) and EBITDA of -₹46.85 Lakh (EBITDA margin -224.4%).
As per MCA filings, the company has open charges of ₹56.25 Lakh on record.
Company details
Contact details
Iris Super Speciality Polyclinic Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressB – 116 Kailash Industrail Complex Veer Savarkar Marg Park Site Vikhroli, West, Mumbai, Maharashtra, India – 400079
- IndustryHealthcare, Preventive Health Services
To see the full contact details of Iris Super Speciality Polyclinic Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Iris Super Speciality Polyclinic is human health and social work activities. In detail, this covers human health activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities |
To see the full business activity and turnover split of Iris Super Speciality Polyclinic Private Limited, buy the company report.
Financials of Iris Super Speciality Polyclinic Private Limited
FY 2025 filings availableIris Super Speciality Polyclinic Private Limited reported revenue of ₹20.88 Lakh (down 12% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue fell 12% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹20.88 Lakh | ||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹46.85 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹80.34 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -224.4% | ||
| Net Profit Margin | -384.8% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Iris Super Speciality Polyclinic Private Limited, buy the company report.
Board of directors of Iris Super Speciality Polyclinic Private Limited
Iris Super Speciality Polyclinic has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Varadan Seshadri Cetlur | Director | 17 Mar 2020 | 6 Years 7 Months | Current |
| Ashok Kumar Singh Also directs: Self Heal Lifesciences Private Limited, Sitoma Health Care LLP | Director | 17 Mar 2020 | 6 Years 7 Months | Current |
| Sanjeev Kumar Shyamsunder Dudeja | Director | 17 Mar 2020 | 6 Years 7 Months | Current |
Auditor
Iris Super Speciality Polyclinic Private Limited is audited by S SHARMA & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S SHARMA & ASSOCIATES | FY 2022 | 130466W |
Shareholding
The shareholding of Iris Super Speciality Polyclinic Private Limited is on record for 3 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Iris Super Speciality Polyclinic Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 08 Jun 2021 | 100456569 | Indian Bank | ₹11.25 Lakh | Open | |
| 09 Mar 2021 | 100427112 | Indian Bank | ₹45 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Iris Super Speciality Polyclinic Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Iris Super Speciality Polyclinic Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Iris Super Speciality Polyclinic Private Limited has 1 active EPFO establishment as of Apr 07, 2024.
GST
Iris Super Speciality Polyclinic has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAFCI6168M1ZZ | Maharashtra | Active | 20 Sep 2020 |
To see the full GST registrations and return filing status of Iris Super Speciality Polyclinic Private Limited, buy the company report.
Recent activity
Iris Super Speciality Polyclinic Private Limited has 3 board changes on record since 2020: 3 appointments. The latest: Ashok Kumar Singh was appointed as Director on 17 Mar 2020.
Frequently asked questions
Iris Super Speciality Polyclinic is an active private limited company based in Mumbai, Maharashtra, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 17 March 2020 (6+ years old) and is registered under CIN U85100MH2020PTC338934.
Iris Super Speciality Polyclinic has 3 current directors:
- Varadan Seshadri Cetlur - Director
- Ashok Kumar Singh - Director
- Sanjeev Kumar Shyamsunder Dudeja - Director
The latest financial statements of Iris Super Speciality Polyclinic on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Iris Super Speciality Polyclinic is 27AAFCI6168M1ZZ, registered in Maharashtra.
The CIN (Corporate Identification Number) of Iris Super Speciality Polyclinic is U85100MH2020PTC338934. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Iris Super Speciality Polyclinic was incorporated on 17 March 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
Ashok Kumar Singh was appointed as Director on 17 Mar 2020. Sanjeev Kumar Shyamsunder Dudeja was appointed as Director on 17 Mar 2020. Varadan Seshadri Cetlur was appointed as Director on 17 Mar 2020.
The registered office of Iris Super Speciality Polyclinic is at B – 116 Kailash Industrail Complex Veer Savarkar Marg Park Site Vikhroli, West, Mumbai, Maharashtra, India – 400079.
Iris Super Speciality Polyclinic operates in the healthcare industry, in the preventive health services segment.
Iris Super Speciality Polyclinic has open charges of ₹56.25 Lakh and no satisfied charges on record as per latest MCA filings.